The market views the company's poor revenue performance as a...
The market views the company's poor revenue performance as a potential future underperformance. Despite strong three-year revenue trends, shareholders seem to think recent performance has peaked, accepting lower selling prices. There may be significant risks to the company's profitability, possibly pressuring the P/S ratio.
Investors Give Wai Yuen Tong Medicine Holdings Limited (HKG:897) Shares A 46% Hiding
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment